Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?

ESMO Open. 2020 Jul;5(Suppl 3):e000836. doi: 10.1136/esmoopen-2020-000836.
No abstract available

Keywords: Covid-19; breast cancer; multigene assays; neoadjuvant endocrine therapy.

Publication types

  • Letter
  • Comment